Mahmoud Al Rifai

1 ta ish

Baylor College of Medicine

1. PCSK9-targeted therapies: present and future approaches

   Mahmoud Al Rifai, Christie M. Ballantyne

   Sharh maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.216662